It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group

Posttraumatic Stress Disorder in the National Comorbidity Survey

Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379

Clinician-administered PTSD scale: A review of the first ten years of research

Weathers, F. W., Keane, T. M., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1029 · Cited by 1,903

Biological studies of post-traumatic stress disorder

Pitman, R. K., Rasmusson, A. M., Koenen, K. C., Shin, L. M., Orr, S. P., Gilbertson, M. W., Milad, M. R., & Liberzon, I. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3339 · Cited by 1,529

Post-Traumatic Stress Disorder in the General Population

Helzer, J. E., Robins, L. N., & McEvoy, L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172604 · Cited by 1,199

Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design

Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076

Medication Augmentation after the Failure of SSRIs for Depression

Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002

Traumatic events and post‐traumatic stress disorder in the community: prevalence,risk factors and comorbidity

Perkonigg, A., Kessler, R. C., Storz, S., & Wïttchen, H. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101001046.x · Cited by 999

Prevalence of Mental Health Problems and Functional Impairment Among Active Component and National Guard Soldiers 3 and 12 Months Following Combat in Iraq

Thomas, J. L., Wilk, J. E., Riviere, L. A., McGurk, D., Castro, C. A., & Hoge, C. W. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.54 · Cited by 942

Efficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder

Brady, K. T., Pearlstein, T. B., Asnis, G. M., Baker, D. G., ROTHBAUM, B. O., Sikes, C. R., & Farfel, G. M. (2000) · JAMA · doi:10.1001/jama.283.14.1837 · Cited by 707

What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression

Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661

The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice

Zhou, C., Assareh, N., & Arnold, J. C. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0027 · Cited by 16

Protocol for individual participant data meta-analysis of interventions for post-traumatic stress

Wright, S. L., Karyotaki, E., Bisson, J. I., Cuijpers, P. J., Papola, D., Witteveen, A. B., Seedat, S., & Sijbrandij, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054830 · Cited by 16

Enhancing Access to Psychiatric Care for Posttraumatic Stress Disorder in Veterans with Mild Traumatic Brain Injury through Integrated Services

Baig, M. R., Tapia, R. N., Meraj, A., Pugh, J. A., Roache, J. D., & Finley, E. P. (2019) · Psychiatric Quarterly · doi:10.1007/s11126-019-09668-7 · Cited by 16

Ketamine treatment upon memory retrieval reduces fear memory in marmoset monkeys

Philippens, I. H. C. H. M., Draaisma, L. R., Baarends, G., Krugers, H. J., & Vermetten, E. H. G. J. M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.04.004 · Cited by 17

Neurochemical, Neurocircuitry, and Psychopathological Mechanisms of PTSD: Emerging Pharmacotherapies and Clinical Perspectives

Prajapati, S. K., Majumdar, S., Murari, S., MachhindraVadak, K., & Krishnamurthy, S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00335 · Cited by 16

Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial

McGowan, N. M., Rucker, J., Yehuda, R., Agrawal, M., Modlin, N. L., Simmons, H., Tofil-Kaluza, A., Das, S., & Goodwin, G. M. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251362390 · Cited by 22

Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response

Sullivan, G. M., Gendreau, R. M., Gendreau, J., Peters, P., Peters, A., Engels, J., Daugherty, B. L., Vaughn, B. J., Weathers, F. W., & Lederman, S. M. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113974 · Cited by 17

Transcriptome profiles associated with resilience and susceptibility to single prolonged stress in the locus coeruleus and nucleus accumbens in male sprague-dawley rats

Nahvi, R. J., Tanelian, A., Nwokafor, C., Godino, A., Parise, E. M., Estill, M. S., Shen, L., Nestler, E. J., & Sabban, E. L. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114162 · Cited by 18

Aerobic Exercise Improves the Overall Outcome of Type 2 Diabetes Mellitus Among People With Mental Disorders

He, J., Liu, F., Xu, P., Xu, T., Yu, H., Wu, B., Wang, H., Chen, J., Zhang, K., Zhang, J., et al. (2024) · Depression and Anxiety · doi:10.1155/da/6651804 · Cited by 18

Clinical outcomes of recommended active pharmacotherapy agents from NICE guideline for post-traumatic stress disorder: Network meta-analysis

Zhang, Z., Liu, R.-B., Zhang, J., Xian‐Yu, C., Liu, J.-L., Li, X., Zhang, Y., & Zhang, C. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110754 · Cited by 15

Ethics of Psychedelic Use in Psychiatry and Beyond—Drawing upon Legal, Social and Clinical Challenges

Azevedo, N., da Silva, M. O., & Madeira, L. (2023) · Philosophies · doi:10.3390/philosophies8050076 · Cited by 15

Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder

Davis, L. L., Behl, S., Lee, D. J., Zeng, H., Skubiak, T., Weaver, S., Hefting, N., Larsen, K. G., & Hobart, M. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.3996 · Cited by 15

Trauma under psychedelics: how psychoactive substances impact trauma processing

Netzer, O., Magal, N., Stern, Y., Polinsky, T., Gross, R., Admon, R., & Salomon, R. (2025) · World Psychiatry · doi:10.1002/wps.21363 · Cited by 15

Enhancing Completion of Cognitive Processing Therapy for Posttraumatic Stress Disorder with Quetiapine in Veterans with Mild Traumatic Brain Injury: a Case Series

Baig, M. R., Wilson, J. L., Lemmer, J. A., Beck, R. D., Peterson, A. L., & Roache, J. D. (2019) · Psychiatric Quarterly · doi:10.1007/s11126-019-09638-z · Cited by 14

Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT1A Receptor Partial Agonist/5-HT6 Receptor Full Agonist

Liu, W.-G., Zhang, L., Yao, J.-Q., Yin, Y., Zhang, X., Li, Y., & Cao, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.625547 · Cited by 13

Measurement Strategies for Evidence-Based Antidepressants for Posttraumatic Stress Disorder Delivery: Trends and Associations with Patient-Reported Outcomes

Shiner, B. R., Leonard, C. E., Gui, J., Cornelius, S. L., Gradus, J. L., Schnurr, P. P., & Watts, B. V. (2020) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-020-01047-w · Cited by 14

A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder

Feder, A., Costi, S., Rutter, S., Collins, A. B., Govindarajulu, U. S., Jha, M. K., Horn, S. R. G.-V., Kautz, M. M., Corniquel, M., Collins, K. A., et al. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021014 · Cited by 12

A Pilot Study Comparing a Community of Practice Program with and without Concurrent Ketamine-Assisted Therapy

Tsang, V. W. L., Ragazan, D. C., Kryskow, P., Walsh, Z., & Dames, S. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2253798 · Cited by 14

Impact of Academic Detailing on Benzodiazepine Use among Veterans with Posttraumatic Stress Disorder

Bounthavong, M., Lau, M. K., Popish, S. J., Kay, C. L., Wells, D. L., Himstreet, J. E., Harvey, M. A., & Christopher, M. L. D. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1573777 · Cited by 12

Animal models for the discovery of novel drugs for post-traumatic stress disorder

Zoladz, P. R. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1820982 · Cited by 12

Development, validation and standardization of oromucosal ex-vivo permeation studies for implementation in quality-controlled environments

Majid, H., Bartel, A., & Burckhardt, B. B. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113769 · Cited by 12

Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial

Telch, M. J., Fischer, C. M., Zaizar, E. D., Rubin, M., & Papini, S. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106933 · Cited by 13

Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy

Gully, B. J., Eaton, E. M., Capone, C., & Haass‐Koffler, C. L. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231200880 · Cited by 12

Leveraging genetics to enhance the efficacy of PTSD pharmacotherapies

Miller, M. W. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.039 · Cited by 13

Is There a Role for Vagus Nerve Stimulation in the Treatment of Posttraumatic Stress Disorder?

McIntyre, C. K. (2018) · Bioelectronics in Medicine · doi:10.2217/bem-2018-0002 · Cited by 12

Increased prevalence of metabolic syndrome in Veterans with PTSD untreated with antipsychotic medications

Palmer, B. W., Shir, C., Chang, H., Mulvaney, M., Hall, J. M. H., Shu, I.-W., Jin, H., & Lohr, J. B. (2021) · International Journal of Mental Health · doi:10.1080/00207411.2021.1965398 · Cited by 11

Study of Psychophysiological Indicators of Sensorimotor Integration in PTSD. Justification of the Choice of Targets for Biofeedback

Bazanova, O. M., Балиоз, Н. В., Ermolaeva, S. А., Zakharov, A. V., Zonov, A. A., Larkova, I., Mariyanovska, T. А., Melnikov, А. А., Nikolenko, E. D., Plotnikova, E. P., et al. (2024) · Human Physiology · doi:10.1134/s036211972360056x · Cited by 10

Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries

Reinhard, M. A., Seifert, J., Greiner, T., Toto, S., Bleich, S., & Grohmann, R. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01223-x · Cited by 11

Efficacy of Vortioxetine Monotherapy for Posttraumatic Stress Disorder

Dunlop, B. W., Rakofsky, J. J., Newport, D. J., Mletzko, T., Barone, K., Nemeroff, C. B., & Harvey, P. D. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001363 · Cited by 10

Augmenting Treatment for Posttraumatic Stress Disorder and Co-Occurring Conditions with Oxytocin

Flanagan, J. C., & Mitchell, J. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-019-00171-1 · Cited by 12

Integrating Unified Medical Language System and Kleinberg’s Burst Detection Algorithm into Research Topics of Medications for Post-Traumatic Stress Disorder

Xu, S., Xu, D., Wen, L. G., Zhu, C., Yang, Y., Han, S., & Guan, P. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s270379 · Cited by 10

Mining Clinical Data for Novel Posttraumatic Stress Disorder Medications

Shiner, B. R., Forehand, J. A., Rozema, L. R., Kulldorff, M., Watts, B. V., Trefethen, M., Jiang, T., Huybrechts, K. F., Schnurr, P. P., Vincenti, M. P., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.10.008 · Cited by 12

The Walking Wounded: Emerging Treatments for PTSD

Bestha, D. P., Soliman, L., Blankenship, K. M., & Rachal, J. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0941-8 · Cited by 12

Treatment Resistance in Post-traumatic Stress Disorder

McFARLANE, A. C. (2018) · Springer eBooks · doi:10.1007/978-981-10-4358-1_10 · Cited by 12

Theranostic pharmacology in PTSD: Neurobiology and timing

Koek, R. J., & Luong, T. N. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.001 · Cited by 10

A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder

Parmenter, M. E., Lederman, S. M., Weathers, F. W., Davis, L. L., Vaughn, B. J., Engels, J., & Sullivan, G. M. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115764 · Cited by 10

Using natural language processing to evaluate temporal patterns in suicide risk variation among high-risk Veterans

Levis, M., Levy, J., Dimambro, M., Dufort, V., Ludmer, D. J., Goldberg, M., & Shiner, B. R. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116097 · Cited by 11

Resting-state connectivity subtype of comorbid PTSD and alcohol use disorder moderates improvement from integrated prolonged exposure therapy in Veterans

Stout, D. M., Harlé, K. M., Norman, S. B., Simmons, A. N., & Spadoni, A. D. (2021) · Psychological Medicine · doi:10.1017/s0033291721001513 · Cited by 9

The Impact of Electroacupuncture Early Intervention on the Brain Lipidome in a Mouse Model of Post-traumatic Stress Disorder

Zhou, C., Xue, F., Shi, Q., Xue, S., Zhang, T., Ma, X., Yu, L., Liu, C., Wang, H., & Peng, Z. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.812479 · Cited by 9

D-Pinitol mitigates post-traumatic stress disorder-like behaviors induced by single prolonged stress in mice through mineralocorticoid receptor antagonism

Kong, C. H., Lee, J. W., Jeon, M., Kang, W. C., Kim, M. S., Park, K., Bae, H. J., Park, S. J., Jung, S. Y., Kim, S., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110990 · Cited by 9

An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma

Smith, F. N., Neill, J. C., & Wainwright, V. (2022) · Drug Science Policy and Law · doi:10.1177/20503245221124117 · Cited by 10

Enhancing cultural competencies of advanced practice nurses: health care challenges in the twenty-first century.

Ndiwane, A. N., Miller, K., Bonner, A., Imperio, K., Matzo, M. L., McNeal, G. J., Amertil, N. P., & Feldman, Z. T. (2004) · PubMed · Cited by 9

Pragmatic Comparative Effectiveness of Primary Care Treatments for Posttraumatic Stress Disorder

Fortney, J. C., Kaysen, D. L., Engel, C. C., Cerimele, J. M., Nolan, J. P., Chase, E., Blanchard, B. E., Hauge, S., Bechtel, J. M., Taylor, A., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.2962 · Cited by 9

Autonomic regulation during sleep in PTSD

Woodward, S. H. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100483 · Cited by 8

Mechanism of action of sedatives, hypnotics, and antianxiety drugs

Nisar, M. A., & Saleem, M. Z. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99855-0.00007-5 · Cited by 7

The Role of the Glutamate System in Posttraumatic Stress Disorder and Glutamate-Based Treatments

Popoli, M., Ieraci, A., & Musazzi, L. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_5 · Cited by 8

Using patient‐reported outcomes to understand the effectiveness of guideline‐concordant care for post‐traumatic stress disorder in clinical practice

Shiner, B. R., Gui, J., Westgate, C. L., Schnurr, P. P., Watts, B. V., Cornelius, S. L., & Maguen, S. (2019) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13158 · Cited by 8

Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?Preprint

Oña, G., & Bouso, J. C. (2019) · Preprints.org · doi:10.20944/preprints201901.0249.v1 · Cited by 8

Modulating amygdala activation to traumatic memories with a single ketamine infusionPreprint

Duek, O. A., Li, Y., Kelmendi, B., Amen, S. L., Gordon, C., Milne, M., Krystal, J. H., Levy, I., & Harpaz‐Rotem, I. (2021) · medRxiv · doi:10.1101/2021.07.07.21260166 · Cited by 7

Psychedelic drugs as a long-needed innovation in psychiatryPreprint

Oña, G., & Bouso, J. C. (2020) · Qeios · doi:10.32388/t3em5e · Cited by 7

Dynamic suicide topic modelling: Deriving population‐specific, psychosocial and time‐sensitive suicide risk variables from Electronic Health Record psychotherapy notes

Levis, M., Levy, J., Dufort, V., Russ, C. J., & Shiner, B. R. (2023) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2842 · Cited by 9

Mindfulness-Based Interventions for Psychological Trauma and Posttraumatic Stress Disorder (PTSD)

Badola, A., Yu, W., & King, A. P. J. (2025) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-025-00364-x · Cited by 8

Psychedelics and collective trauma: multisystemic resilience and recovery pathways among Nova festival survivors – a qualitative study

Simon, G., Gal-Birman, M., Tadmor, N., Halperin, D., & Ben‐Zion, Z. (2025) · European Journal of Psychotraumatology · doi:10.1080/20008066.2025.2582303 · Cited by 7

Discontinuation and nonpublication of clinical trials for the pharmacologic treatment of posttraumatic stress disorder among military veterans

Weygandt, J., Moody, M., Sajjadi, N. B., Greiner, B. H., Ford, A. I., Mazur, A., & Hartwell, M. L. (2023) · Journal of Traumatic Stress · doi:10.1002/jts.22911 · Cited by 7

Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot study

Baig, M. R., Beck, R. D., Wilson, J. L., Lemmer, J. A., Meraj, A., Meyer, E. C., Mintz, J., Peterson, A. L., & Roache, J. D. (2020) · Military Medical Research · doi:10.1186/s40779-020-00278-0 · Cited by 7

Targeting PTSD

McDonald, W. M., & van Rooij, S. J. H. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19080895 · Cited by 7

Acute prazosin administration does not reduce stressor reactivity in healthy adults

Kaye, J. T., Fronk, G. E., Zgierska, A. E., Cruz, M. R., Rabago, D., & Curtin, J. J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05297-x · Cited by 7

Comparative Effectiveness of Direct-Acting Antivirals for Posttraumatic Stress Disorder in Veterans Affairs Patients With Hepatitis C Virus Infection

Shiner, B. R., Huybrechts, K. F., Gui, J., Rozema, L. R., Forehand, J. A., Watts, B. V., Jiang, T., Hoyt, J. E., Esteves, J., Schnurr, P. P., et al. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac104 · Cited by 9

Post-traumatic stress disorder in Australia: 2020

Wallace, D. (2020) · Australasian Psychiatry · doi:10.1177/1039856220922245 · Cited by 7

Deletion of p75NTR rescues behavioral and cognitive dysfunction in SPS-induced PTSD mice through hippocampal PI3K/Akt/mTOR pathway

Peng, Y.-Y., Tang, J., Li, S., Tang, C. L., Ding, Y., Cheng, Y.-F., Wang, H., Long, Z.-Y., Lu, X., & Wang, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142770 · Cited by 6

Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings

Calnan, M., Blest‐Hopley, G., Busch, C., Adams, M., Ruffell, S., Piper, T., Roseman, L., Kettner, H., & Carhart-Harris, R. L. (2025) · Brain and Behavior · doi:10.1002/brb3.70660 · Cited by 10

Heritable Differences in Catecholamine Signaling Modulate Susceptibility to Trauma and Response to Methylphenidate Treatment: Relevance for PTSD

Deslauriers, J., Tóth, M., Zhou, X., & Risbrough, V. B. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00111 · Cited by 7

Quetiapine as an adjunct to enhance engagement in prolonged exposure therapy for PTSD in veterans: A randomized, pilot trial

Baig, M. R., Wilson, J. L., Beck, R. D., Lemmer, J. A., Hernandez, A. L., Meraj, A., Tapia, R. N., Meyer, E. C., Mintz, J., Peterson, A. L., et al. (2022) · Journal of Behavioral and Cognitive Therapy · doi:10.1016/j.jbct.2022.04.001 · Cited by 6

Metabotropic glutamate receptor function and regulation of sleep-wake cycles

Holter, K. M., Pierce, B. E., & Gould, R. W. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2022.11.002 · Cited by 6

BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder

Papapetropoulos, S., Doolin, E., O’Connor, S., Paul, D., Odontiadis, M., Jaros, M., Rolan, P., & Stein, M. B. (2025) · NEJM Evidence · doi:10.1056/evidoa2400380 · Cited by 5

Post-traumatic stress disorder

Ressler, K. J., Rothbaum, B. O., Schnurr, P. P., Binder, E., Moreland-Capuia, A. R., Nievergelt, C. M., Koenen, K. C., Seedat, S., Shalev, A. Y., Marmar, C. R., et al. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00701-1 · Cited by 6

A Collaborative Psychopharmacology Research Agenda for Posttraumatic Stress Disorder

Gordon, J. A., Borja, S. E., & Tuma, F. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.019 · Cited by 5

Differential effects of α4β2 nicotinic receptor antagonists and partial-agonists on contextual fear extinction in male C57BL/6 mice

Kutlu, M. G., Tumolo, J. M., Cann, C., & Gould, T. J. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4837-4 · Cited by 6

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel

Cipriani, A., & Cowen, P. J. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30170-6 · Cited by 5

Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment

Modlin, N. L., Williamson, V., Goodwin, G. M., Malievskaia, E., Atli, M., Elek, Z., Gaillard, A., Koelpin, D., Cleare, A. J., Agrawal, M., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103692 · Cited by 4

Combining DNA methylation features and clinical characteristics predicts ketamine treatment response for PTSD

Valizadeh, A., Roache, J. D., Zhang, X., Hu, Y., Gueorguieva, R. V., Averill, L. A., Ranganathan, M., Wang, Z., Williamson, D. E., Shiroma, P. R., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114445 · Cited by 3

The effect of obstructive sleep apnea severity on PTSD symptoms during the course of esketamine treatment: a retrospective clinical study

Titone, M. K., Hunt, C., Bismark, A. W., Nokes, B. T., Lee, E., Ramanathan, D., Park, J., & Colvonen, P. J. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10746 · Cited by 4

PTSD Treatment Problems at the U.S. Veterans Administration

Koven, S. G. (2021) · Psychiatry International · doi:10.3390/psychiatryint2010002 · Cited by 4

Driving Progress in Posttraumatic Stress Disorder Biomarkers

Jeromin, A., Lasseter, H. C., Provost, A. C., Daskalakis, N. P., Etkin, A., Gehrman, P., Lancashire, L., Marx, B. P., McGlinchey, R. E., & Haas, M. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.036 · Cited by 4

It Is Time to Look for New Treatments for Posttraumatic Stress Disorder: Can Sympathetic System Modulation Be an Answer?

Lipov, E., Tukan, A., & Candido, K. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.07.026 · Cited by 4

Psychedelic drugs as a long-needed innovation in psychiatryPreprint

Oña, G., & Bouso, J. C. (2020) · Qeios · doi:10.32388/t3em5e.2 · Cited by 3

MDMA Assisted Psychotherapy Decreases PTSD Symptoms, Dissociation, Functional Disability, and Depression: A Systematic Review and Meta-AnalysisPreprint

Green, W. M., Raut, S. B., James, F., Benedek, D. M., Ursano, R. J., & Johnson, L. R. (2023) · medRxiv · doi:10.1101/2023.08.17.23293955 · Cited by 4

Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework

Modlin, N. L., Williamson, V., Maggio, C., Stubley, J., Kirlić, N., Cleare, A. J., & Rucker, J. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251342319 · Cited by 3

Optimal exercise dosage and type for improving post-traumatic stress disorder: a systematic review and network meta-analysis of randomized controlled trials

Li, X.-J., Xia, H., Yu, G.-H., Hu, Y., & Zhu, F. (2025) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2025.102004 · Cited by 3

Mental Health Research in the Department of Veterans Affairs

Reger, M. A., & Smyth, M. J. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.1808 · Cited by 3

The attentional bias towards threat in posttraumatic stress disorder: Evidence from eye movement studies

Bai, Y., & Yang, H. (2021) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2021.00737 · Cited by 3

The impact of doxycycline on human contextual fear memory

Wehrli, J. M., Xia, Y., Abivardi, A., Kleim, B., & Bach, D. R. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06540-w · Cited by 3

Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression

Swanberg, K. M., Prinsen, H., Averill, C. L., Campos, L., Kurada, A. V., Krystal, J. H., Petrakis, I. L., Averill, L. A., Rothman, D. L., Abdallah, C. G., et al. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5220 · Cited by 4

Hippocampal connectivity changes after traumatic memory reactivation with propranolol for posttraumatic stress disorder: a randomized fMRI study

Véry, E., Leroy, A., Richaud, L., Vaïva, G., Jardri, R., Roullet, P., Taïb, S., Bourcier, A., Loubinoux, I., & Birmes, P. J. (2025) · European Journal of Psychotraumatology · doi:10.1080/20008066.2025.2466886 · Cited by 4

Inhibition of indoleamine 2,3-dioxygenase by 1-methyl-D-tryptophan (1-MT) rescued PTSD-like symptoms via downregulation of neuroinflammation and NMDA receptor

Rakeshkumar, P. P., Maharana, K. C., ‬‬‬‬‬‬‬Bommaraju, S., Dhokne, M. D., & Datusalia, A. K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178122 · Cited by 3

Transforming Health and Resiliency Through Integration of Values-based Experiences: Implementation of an Electronic Evidence-based Whole Health Clinical Program

Haun, J. N., Paykel, J. M., & Melillo, C. (2021) · JMIR Formative Research · doi:10.2196/26030 · Cited by 3

Sequenced Treatment Effectiveness for Posttraumatic Stress (STEPS) Trial: A protocol for a pragmatic comparative effectiveness trial with baseline results

Fortney, J. C., Kaysen, D. L., Engel, C. C., Cerimele, J. M., Nolan, J. P., Chase, E., Blanchard, B. E., Hauge, S., Bechtel, J. M., Moore, D. L., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107606 · Cited by 3

A retrospective analysis of ketamine intravenous therapy for post-traumatic stress disorder in real-world care settings

McInnes, L. A., Berman, R., Worley, M. J., & Shih, E. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116689 · Cited by 4

Posttraumatische Belastungsstörungen

Frommberger, U., Nyberg, E., Angenendt, J., Lieb, K., & Berger, T. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-22485-0.00014-2 · Cited by 3

Remediation of PTSD in a Combat Veteran: A Case Study

Lindenfeld, G. L., Rozelle, G., Hummer, J. T., Sutherland, M. R., & Miller, J. C. (2019) · NeuroRegulation · doi:10.15540/nr.6.2.102 · Cited by 3

Response to the Consensus Statement of the PTSD Psychopharmacology Working Group

Feduccia, A. A., Mithoefer, M. C., Jerome, L., Holland, J. A., Emerson, A., & Doblin, R. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.023 · Cited by 3

Post-traumatic stress disorder in psychedelic research

Bostoen, T., Tap, S. C., Breeksema, J. J., & Schoevers, R. A. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.02.004 · Cited by 2

Mystical experiences during magnesium-Ibogaine are associated with improvements in PTSD symptoms in veterans

Brown, R. E., Lissemore, J. I., Shinozuka, K., Coetzee, J. P., Faerman, A., Olash, C., Geoly, A. D., Buchanan, D. M., Cherian, K. N., Chaiken, A., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120722 · Cited by 2

An explainable predictive machine learning model reveals ARRB2 as a key gene in post-traumatic stress disorder: A GEO database study

Wu, L., Fu, Q., Gao, Y., Jiang, B., Zheng, H., Zhong, Z., Zhang, G., Lu, Y., Zhang, Z., Li, R., et al. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.12.037 · Cited by 2

Residential Therapy With Navigated Transcranial Magnetic Stimulation for Combat-Related PTSD

Fox, P. T., Salinas, F. S., Roache, J. D., Quinones, M. P., Vaughan, P. W., Franklin, C. G., Straud, C. L., Price, L. R., Unzueta-Hernandez, M., Woolsey, M. K., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.5110 · Cited by 2

Treating PTSD: A review of 8 studies

Saeed, S. A. (2023) · Current Psychiatry · doi:10.12788/cp.0324 · Cited by 2

Study of psychophysiological indicators of sensorimotor Integration in PTSD. Justification of the choice of targets for biofeedback

Bazanova, O. M., Балиоз, Н. В., Ermolaeva, S. А., Zakharov, A. V., Zonov, A. A., Larkova, I., Mariyanovska, T. А., Melnikov, А. А., Nikolenko, E. D., Plotnikova, E. P., et al. (2024) · Human Physiology · doi:10.31857/s0131164624030061 · Cited by 2

An Anti‐Amyloidogenic Approach to Specifically Block Memory Consolidation in Mice for Therapeutic Intervention

López-García, P., McGreevy, K. R., Vaquero, M. E., Suarez‐Rivero, J. M., Moreno-Rodríguez, A., Pérez‐Pulido, A. J., de Mingo, D. R., Pallé, A., Popiel, H. A., Santi, A., et al. (2026) · Advanced Science · doi:10.1101/2025.01.27.635080 · Cited by 3

Spreading depolarization induced by amygdala micro-injury prevents disruption of fear memory extinction in rats

Rysakova, M. P., Pavlova, I. V., & Vinogradova, L. V. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113559 · Cited by 3

Post-traumatic Stress Disorder in Middle Age and Beyond

Marshall, L. L., & Hayslett, R. L. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.191 · Cited by 2

The PTSD Psychopharmacology Working Group: Two Suggestions

Jindal, R. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.004

Response to the Consensus Statement of the PTSD Psychopharmacology Working Group

Feduccia, A. A., Mithoefer, M. C., Jerome, L., Holland, J. A., Emerson, A., & Doblin, R. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.023 · Cited by 3

A Collaborative Psychopharmacology Research Agenda for Posttraumatic Stress Disorder

Gordon, J. A., Borja, S. E., & Tuma, F. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.019 · Cited by 5

It Is Time to Look for New Treatments for Posttraumatic Stress Disorder: Can Sympathetic System Modulation Be an Answer?

Lipov, E., Tukan, A., & Candido, K. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.07.026 · Cited by 4

Reply to: It Is Time to Look for New Treatments for Posttraumatic Stress Disorder: Can Sympathetic System Modulation Be an Answer?

Krystal, J. H., Davis, L. L., Neylan, T. C., Raskind, M. A., Schnurr, P. P., Stein, M. B., Vessicchio, J. C., Shiner, B. R., Gleason, T., & Huang, G. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.09.031 · Cited by 1